Reason for withdrawal from publication
Reasons for withdrawal of review: This review is out of date and could be misleading and has therefore been withdrawn. New reviews now exist on The Cochrane Library for carbamazepine, gabapentin, lamotrigine and pregabalin. The review team is currently updating carbamazepine and lamotrigine. Other anticonvulsants such as clonazepam, phenytoin and sodium valproate will be incorporated into a new updated review.
The editorial group responsible for this previously published document have withdrawn it from publication.
What's new
| Date | Event | Description |
|---|---|---|
| 4 September 2009 | Amended | Reasons for withdrawal of review: This review is out of date and could be misleading and has therefore been withdrawn. New reviews now exist on The Cochrane Library for carbamazepine, gabapentin, lamotrigine and pregabalin. The review team is currently updating carbamazepine and lamotrigine. Other anticonvulsants such as clonazepam, phenytoin and sodium valproate will be incorporated into a new updated review. |
History
Review first published: Issue 3, 1997
| Date | Event | Description |
|---|---|---|
| 12 November 2008 | Amended | Contact details updated |
| 7 July 2008 | Amended | Converted to new review format. |
| 10 May 2005 | New search has been performed | At the start of the latest update, 12 new included studies were identified mainly of the newer anticonvulsants gabapentin and lamotrigine. In total the included studies provided data on six different chemical entities used in at least six identified neuropathic pain conditions. Issues of dose response and trial design added to the complexity. A decision was therefore taken to split this review into a number of smaller reviews each covering one chemical entity. Reviews of Carbamazepine and of Gabapentin were published in Issue 3 2005 of The Cochrane Library. The information on these drugs in this review has been superceded. Other drugs remained unchanged at present. |
| 10 May 2005 | New citation required but conclusions have not changed | This search for this review was revised, no further studies are included in this review but the review has been split and reviews on Carbamazepine and Gabapentin are now published separately. |
Sources of support
Internal sources
Oxford Regional Health Authority, UK.
Pain Research Funds, UK.
External sources
Marie Curie Cancer Care, UK.
Withdrawn from publication for reasons stated in the review